Stacking is where peptide culture runs furthest ahead of peptide evidence. Individual compounds at least have animal data; combinations have essentially none, anywhere, in any species. That does not stop stacks from being the default way these compounds are actually used, so here is the honest decomposition: what each popular combo is trying to do, what is known about its parts, and what is known about the whole (nothing).
The rule that governs every stack
Evidence does not add: unknowns multiply. Two compounds that each lack human safety data do not combine into a half-known stack; every interaction (pharmacological, immunological, practical) is a new unknown layered on the existing ones. No popular peptide stack has ever been tested as a combination in a controlled trial, animal or human. Every stack rationale you read is an inference from single-compound data.
The popular stacks, decomposed
| Stack | The theory | The evidence reality |
|---|---|---|
| BPC-157 + TB-500 ('Wolverine') | Local repair signal plus systemic repair signal | Each has rodent healing data; the combination has zero studies. The name comes from a comic book, which is honest branding. |
| CJC-1295 + ipamorelin | GHRH pathway plus ghrelin pathway for bigger GH pulses | The synergy is real pharmacology (documented for the receptor classes); outcome benefits in healthy adults remain unproven for either, alone or together. FDA Category 2 applies. |
| GLP-1 + GH secretagogue | Lose fat while 'protecting muscle' via GH | GLP-1 efficacy is proven; the muscle-protection add-on is extrapolation. No trial has tested the combination. Resistance training and protein have actual evidence for the same goal. |
| Retatrutide + anything | Amplify the strongest compound | Retatrutide alone is an unapproved Phase 3 drug; adding a second unapproved compound multiplies the exact risks the FDA has warned about. |
| BPC-157 + KPV (gut stack) | Two gut-repair signals | Both have gut-focused preclinical data; the combination is untested, and neither has controlled human data alone. |
The math changes when vials multiply
- Separate vials, separate math: each compound keeps its own concentration and draw. Run the calculator once per vial, never average anything.
- Same-syringe mixing: chemically risky (pH and stability differ per peptide), and it destroys your ability to attribute a side effect to a compound. Pharmaceutical practice reconstitutes and injects separately.
- Blend vials (pre-mixed): the label states total mg; you need the per-component breakdown to compute anything. Our blend calculator covers this case.
- Error surface scales: two vials double the mcg/mg confusion opportunities the FDA has documented hospitalizations for.
If you stack anyway: the harm-reduction logic
One variable at a time is not wellness advice, it is experimental design: introduce compounds sequentially with weeks between, so any effect (good or bad) has an attributable cause. Baseline labs before anything, since GH-axis and metabolic compounds move glucose and IGF-1. And every compound in a stack keeps its own regulatory and anti-doping status: a stack is prohibited in sport if any component is, which for the popular ones means all of them.
Frequently asked questions
What is the best peptide stack?
No stack has controlled evidence, so 'best' has no measurable answer. The popular ones (BPC-157 + TB-500 for recovery, CJC-1295 + ipamorelin for GH) are theory-driven combinations of individually unproven compounds. The honest ranking of any stack is: unknown.
Can you mix peptides in the same syringe?
Standard practice is no: peptides differ in pH and stability, co-mixing is chemically unpredictable, and it makes side effects unattributable. Reconstitute and inject separately; only pre-made blend vials are formulated for coexistence.
Is the Wolverine stack safe?
Unknown, squared. BPC-157 and TB-500 each lack human safety data; the combination has never been studied in any species. Both are WADA-prohibited and neither can be legally compounded. The name is from a comic; the safety data is comparable.